ALEXANDRIA, Va., April 9 -- United States Patent no. 12,268,754, issued on April 8, was assigned to TRANSLATE BIO INC. (Waltham, Mass.).
"Composition and methods for treatment of ornithine transcarbamylase deficiency" was invented by Kim Askew (Lexington, Mass.), Jou-Ku Chung (Lexington, Mass.), Frank DeRosa (Lexington, Mass.), Michael Heartlein (Lexington, Mass.), Shrirang Karve (Lexington, Mass.), Thomas McCauley (Lexington, Mass.), Lianne Smith (Lexington, Mass.) and Ann J. Barbier (Lexington, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides, among other things, methods of treating ornithine transcarbamylase deficiency, including administering to a subject in need of tre...